Class Action Signal

Class Action Signal

Class ActionsNews
Class ActionsNewsAboutContact
Public case information

Medpace Holdings Securities Fraud Class Action

Follow to receive email when new source reporting is added to this case. Email delivery also depends on your profile notification settings and a verified email address.

Medpace Holdings · Medpace common stock · Ongoing Litigation

Last updated

Case overview

Defendant company
Medpace Holdings
Product or service
Medpace common stock
Case status
Ongoing Litigation
Lawsuit type
Securities
Reported harm
Misrepresentation

Important dates

Medpace Lead Plaintiff Application
Lead Plaintiff and Investor Contact
Lead Plaintiff Application
Medpace Class Action Investor Inquiry

Participation information

Availability is based on each listed participation option and its deadline.

Medpace Lead Plaintiff Application

Investors who purchased Medpace securities between April 22, 2025 and February 9, 2026, inclusive, were encouraged to contact the Schall Law Firm regarding the case.

Contact the Schall Law Firm to discuss rights and potential appointment as lead plaintiff.

Type
Lead Plaintiff
Status
Deadline passed
Reported proof requirement
Unclear

Lead Plaintiff and Investor Contact

Investors who purchased Medpace Holdings securities between April 22, 2025 and February 9, 2026, inclusive, and suffered a loss were encouraged to contact the Schall Law Firm.

Contact the Schall Law Firm regarding the securities class action and investor rights.

Type
Law Firm Signup
Status
Deadline passed
Reported proof requirement
Unclear

Lead Plaintiff Application

Investors who purchased or otherwise acquired Medpace common stock between April 22, 2025 and February 9, 2026, inclusive, could move the court for appointment as lead plaintiff.

The deadline to move for appointment as lead plaintiff was June 8, 2026.

Type
Lead Plaintiff
Status
Deadline passed
Reported proof requirement
Unclear

Medpace Class Action Investor Inquiry

Purchasers of Medpace Holdings common stock between April 22, 2025 and February 9, 2026, inclusive, were identified as potential class members. The article states that investors could seek appointment as lead plaintiff.

Submit an inquiry through the Rosen Law Firm form. The lead-plaintiff deadline was June 8, 2026. Investors may also remain absent class members and do nothing at this stage.

Type
Law Firm Signup
Status
Deadline passed
Reported proof requirement
Unclear
Submit form for the Medpace class action

Bragar Eagel & Squire investor inquiry

Investors who purchased or acquired Medpace common stock between April 22, 2025 and February 9, 2026.

Call Bragar Eagel & Squire partner Brandon Walker or Melissa Fortunato at (212) 355-4648 to discuss legal rights.

Type
Law Firm Signup
Status
Unknown
Reported proof requirement
Unclear

Rosen Law Firm investor rights inquiry

Purchasers of Medpace Holdings common stock between April 22, 2025 and February 9, 2026.

Contact Rosen Law Firm for information about rights in the lawsuit.

Type
Law Firm Signup
Status
Unknown
Reported proof requirement
Unclear

Discuss Legal Rights with Bragar Eagel & Squire

Individuals who purchased or acquired Medpace common stock between April 22, 2025 and February 9, 2026.

Call Bragar Eagel & Squire partners Brandon Walker or Melissa Fortunato at (212) 355-4648 to discuss legal rights.

Type
Law Firm Signup
Status
Unknown

Bronstein, Gewirtz & Grossman investor representation

Medpace investors may contact Bronstein, Gewirtz & Grossman regarding representation in the securities class action.

Contact Peretz Bronstein or Nathan Miller at 917-590-0911 or via the email address provided in the article.

Type
Law Firm Signup
Status
Unknown
Reported proof requirement
Unclear
Original article Original article Business Wire source article

This information does not determine whether you qualify for a case.

Sources

Public reporting associated with this case.